IPEM Allocation and Fundraising Trend Report 2027


The private markets industry is entering a new investment cycle, with LPs increasingly focused on diversification, alpha generation and demonstrable value creation, as return expectations come under pressure. This report from Criticaleye Partner AlixPartners, in collaboration with IPEM, analyses allocation and fundraising trends based on data from IPEM Global 2026 attendees, representing more than 1,200 funds.
 
Key takeaways include:

  • More than €114 billion to be allocated in the next 12 months by LPs in attendance at IPEM Global 2026
  • Fundraising timelines continue to be extended, with fewer funds expected to hold a first close in the next 12 months
  • 74 percent of LPs will look for funds in the US next year

Share this with your Community





Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

HR Shared Services Trends Report 2026

The world of HR is evolving rapidly, as organisations look to improve efficiency, embrace AI and enhance the employee experience. This report by LACE Partners looks into how organisations can balance artificial intel...


Click here to download this insight

BLOG | Human Capital at the Crossroad

Artificial intelligence, geopolitical instability and sustained economic uncertainty are reshaping the human capital agenda and placing new demands on Boards. Workforce models, skills requirements, talent strategies ...


Click here to download this insight

Leadership in Times of Radical Change

There are significant changes underway in the UK’s water industry. Phil Aspin, CFO of United Utilities, talks to Criticaleye about adaptability, investment and his own personal journey as a finance leader. A...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 252




Legal & General NATS Mayborn Group London Stock Exchange Group Hitachi Solutions Rolls-Royce LACE Partners Global Payments Stream Lightsource bp Drax Group plc NatWest Group AlixPartners GlaxoSmithKline plc E.ON UK British Land